1. NEUROSYPHILIS AND PENICILLIN LEVELS IN CEREBROSPINAL FLUID.
JAMA: VOL. 236, NO. 19, NOV. 8, 1976, P. 2208-09.

2. PNEUMONIA CAUSED BY STREPTOCOCCUS PYOGENES.
JOSMA: VOL. 69, NO. 23, DEC. 1976, P. 512-16.

3. ANTIBIOTIC-ASSOCIATED OR TOXIN MEDIATED COLITIS, A UNIFYING HYPOTHESIS. JOSMA: VOL. 71, NO. 12, DEC. 1978, P. 453-56.

4. ANTIBIOTIC-ASSOCIATED COLITIS TREATED WITH ORAL VANCOMYCIN. JOSMA: VOL. 72, NO. 12, DEC. 1979, P. 428-29.

5. WASHED SPUTUM GRAM STAIN AND CULTURE IN PNEUMONIA,
JOSMA: VOL. 73, NO. 10, OCT. 1979, P. 354-59.

6. CARBENICILLIN AND PSEUDOMEMBRANOUS ENTEROCOLITIS (LETTER).ANN. INTER. MED.: VOL. 93, NO. 4, OCT. 1980, P. 545.

7. PETRIELLIDIUM BOYDII NECROTIZING PNEUMONIA IN A NORMAL HOST. JAMA: VOL. 245, NO. 6, FEB.13, 1981, P. 605-06.

8. TOXIC SHOCK SYNDROME ASSOCIATED WITH STAPHYLOCOCCAL VAGINITIS.TWELFTH INTERNATIONAL CONGRESS OF CHEMOTHERAPY: ABSTRACT MO. 1114, JUL. 1981, FLORENCE, ITALY.

9. TOXIC SHOCK SYNDROME IN OKLAHOMA.
JOSMA: VOL. 74, NO. 7, JUL. 1981, P. 191-94.

10. PNEUMONIAS IN ADULTS THAT DO NOT RESPOND TO PENICILLIN.
THE OKLAHOMA COUNTY MEDICAL SOCIETY BULLETIN, VOL. 53, NO. 9, NOV. 1981, P. 13.

11. THE GRAM STAIN: A DIAGNOSTIC ORPHAN.THE OKLAHOMA COUNTY MEDICAL SOCIETY BULLETIN. VOL. 54, NO. 3, MAR. 1982, P. 13.

12. THE GRAM STAIN AND CULTURE OF VAGINAL SECRETIONS IN TOXICSHOCK SYNDROME. JOSMA: VOL. 77, NO. 5, MAY 1984, P. 150-51.

13. A CASE OF PANIC DISORDER PRECIPITATED BY OXYMETAZOLINE WITHDRAWAL. THE JOURNAL OF CLINICAL PSYCHIATRY: VOL. 48,  NO. 7, JULY 1987, P. 293.          

14. SUSTAINED HEADACHE SYNDROME ASSOCIATED WITH TENDER OCCIPITAL NERVE ZONES. HEADACHE: VOL. 27, NO. 4, APRIL1987, P. 201-205.

15. ABORTIVE HEADACHE THERAPY WITH INTRAMUSCULAR DIHYDROERGOTAMINE. HEADACHE 1992; 32:18-20.16. ABORTIVE MIGRAINE THERAPY WITH ORAL NAPROXEN SODIUM PLUS METOCLOPRAMIDE PLUS ERGOTAMINE TARTRATE WITH CAFFEINE. HEADACHE 1992, 32:95-97.

17. SAFE RECAPPING OF USED NEEDLES (LETTER)
LANCET VOL. 338, PAGE 695, SEPT. 14, 1991.

18. ABORTIVE HEADACHE THERAPY IN THE OFFICE WITH INTRAVENOUS DIHYDROERGOTAMINE PLUS PROCHLORPERAZINE.
HEADACHE 1992, 32:143-46.

19. VERTIGO ASSOCIATED WITH HYPERLIPIDEMIA; RESPONSE TO ANTILIPIDEMIC THERAPY. 
ARCHIVES OF INTERNAL MEDICINE 1993;153:1846-49.

20. BOOK REVIEW: HANDBOOK OF HEADACHE MANAGEMENT, A PRACTICAL GUIDE TO DIAGNOSIS AND TREATMENT OF HEAD,  NECK, AND FACIAL PAIN.  BY  J.R. SAPER, M.D.,  S. SILBERSTEIN, M.D., C. D. GORDON, M.D.,  R. L. HAMEL, P.A.-C. BALTIMORE: WILLIAMS &  WILKINS. 1993. PP 205. ISBN 0-683-05801-0. HEADACHE 1993, 33:340.

21. POST CHOLECYSTECTOMY BILIARY PAIN AND DYSPEPSIA (RESPONSE  TO 3-HYDROXY-3METHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS). J OKLA STATE MED ASSOC 1994, 87: 31518. 

22. ABORTIVE HEADACHE THERAPY IN THE OFFICE WITH INTRAVENOUS DEXAMETHASONE AND PROCHLORPERAZINE.
HEADACHE 1994;34:366-370.

23. BOOK REVIEW: MANAGING YOUR MIGRAINE, A MIGRAINE SUFFERER’S PRACTICAL GUIDE. BY SUSAN L BURKS, MED., AND FRED D. SHAFTELL, MD, TOTOWA, NEW JERSEY: THE HUMANA PRESS INC. 1994. PAGES 248.$22:50, ESBN 0-89603-277-9. (HEADACHE 1995;35:54)

24. HEADACHE PHOBIA IN MIGRAINE: ABSTRACT, GIVEN AS ORAL  PRESENTATION ON JUNE 25 AT 9 AM AT THE 37TH AASH ANNUAL MEETING IN BOSTON.  HEADACHE 1995;33:294

25. BOOK REVIEW: Management Of Migraine. by Egilius L.H. Spierings, Boston: Butterworth-Heinemann. 1996. Pp150. ISBN 0-7506-9623-0.

26. HEADACHE FEAR.
Journal of the Oklahoma State Medical Association 1997; 90:179-184.

27. Vertigo (Letter To The Editor)
The Lancet, February 13, 1999 Vol.353 Page 591.

28. Headache Fear-Recognition and Management,
Al-HAKEEM, Spring 2008

29. Medical Excess, The American College of Physicians News Letter, December 2009 & Al-HAKEEM Spring 2010

Articles for The Monthly Magazine:

30. The Psychology of Addiction, March 08

31. Fear in Medicine, April 08

32. Headache Disorders, May 08

33. The Journey of Truth from Myth to Science, June 08

34. Preventive Medicine 1&2, July & August 08

35. Anxiety and Panic, September 08

36. The Physical Masques of Depression, October 08

37. Measuring Depression, The Monthly, November 8

38. Understanding Cholesterol, December 08

39. Female Urinary Baldder Infections, January 09

40. Prostate Disorders and Infections, February 09

41. Hormone Replacement Therapy, Marsh 09

42. Thyroid Disorders, April 09

43. Diabetes, May 09

44. High Blood Pressure, June 09

45. Heartburn, August 09

46. Osteoporosis, September 09

47. Acute Back Ache, October 09

48. Chronic Back Ache, November 09

49. Sleep Apnea, December 09

50. Chest Pain, January 10

51. Chronic Cough, February 10

51. Antibiotic Abuse and Overuse, Marsh 10

52. Arthritis, April 10

53. Celiac Disease, May 10

54. Shortness of Breath or 'Dyspnea', June 10

55. Evidence Based Medicine I, The Innate Resistance To Evidence, July 10

56. Evidence Based Medicine II, Levels Of Medical Evidence 1, August 10

57. Evidence Based Medicine III, Levels Of Medical Evidence 2, September 10

58. Evidence Based Medicine IV, The Decline Of Clinical Medicine, October 10

59. Dizziness and Vertigo, November 10

60. Overweight and Obesity, December 10

61. Heart Failure, January 11

62. Hair Loss, February 11

63. Irritable Bowel Syndrome, March 11

64. Herpes Zoster (Shingles), April 11

65. Vitamin D, May 11

66. Movement Disorders, June 11

67. Peripheral Manifestations of Nerve, Artery, and Vein Disorders, July 11

68. Therapeutic Trial, August 11

69. Diverticulosis & Diverticulitis, September 11

70. Gallbladder Attacks, October 11

71. Laryngopharyngeal Reflux, November 11

72. The Dementias, December 11

73. Leg Edema, January 12

74. Fever, February 12

75. Vitamins & Supplements, Marsh 12

76. The Placebo Effect, April 12